Chromatin/Epigenetics(染色质/表观遗传学)
Epigenetics
Epigenetics means above genetics. It determines how much and whether a gene is expressed without changing DNA sequences. Epigenetic regulations include, 1. DNA methylation: the addition of methyl group to DNA, converting cytosine to 5-methylcytosine, mostly at CpG sites; 2. Histone modifications: posttranslational modificationEpigeneticss of histone proteins including acetylation, methylation, ubiquitylation, phosphorylation and sumoylation; 3. miRNAs: non-coding microRNA downregulating gene expression; 4. Prions: infectious proteins viewed as epigenetic agents capable of inducing a phenotype without changing the genome.
Products for Chromatin/Epigenetics
- Bromodomain(47)
- Aurora Kinase(57)
- DNA Methyltransferase(32)
- HDAC(176)
- Histone Acetyltransferases(71)
- Histone Demethylases(99)
- Histone Methyltransferase(204)
- HIF(91)
- JAK(154)
- MBT Domains(1)
- PARP(104)
- Pim(27)
- Protein Ser/Thr Phosphatases(31)
- RNA Polymerase(6)
- Sirtuin(70)
- Sphingosine Kinase-2(1)
- Polycomb repressive complex(2)
- SUMOylation(3)
- PAD(21)
- Epigenetic Reader Domain(205)
- MicroRNA(20)
- Chromodomain(1)
- Citrullination(20)
- DNA/RNA Demethylation(2)
- DNA/RNA Methylation(8)
- Histone Deacetylation(42)
- Histones/Histone Peptides(62)
- PHD Domains(1)
- Tandem Tudor & Tudor-like Domains(1)
- PRMT(2)
- Readers(1)
- Cat.No. 产品名称 Information
-
GC19405
PF-06700841 P-Tosylate
PF-06700841 P-Tosylate
An inhibitor of JAK1 and TYK2 -
GC19398
PIM447
LGH447
PIM447 (LGH447) 是一种有效的、口服的、选择性的泛 PIM 激酶抑制剂,对 PIM1、PIM2 和 PIM3 的 Ki 值分别为 6、18 和 9 pM。 PIM447 具有双重抗骨髓瘤和骨保护作用。 PIM447 诱导细胞凋亡。 -
GC19388
XY1
N-2-萘基-N'-[2-氧代-2-(1-吡咯烷基)乙基]脲
A negative control for SGC707 -
GC19368
Upadacitinib
乌帕替尼; ABT-494
A JAK1 inhibitor - GC19361 TP-3654 A Pim kinase inhibitor
-
GC19360
TMP195
TMP195游离态
TMP195 是一种有效的选择性 IIa 类 HDAC 抑制剂,对 HDAC4、HDAC5、HDAC7 和 HDAC9 的 IC50 分别为 59 nM、60 nM、26 nM 和 15 nM。
- GC19337 SR-4370 An HDAC3 inhibitor
-
GC19334
Solcitinib
索西替尼; GSK-2586184; GLPG-0778
A JAK1 inhibitor - GC19329 SGC2085 A PRMT4/CARM1 inhibitor
- GC19328 SF2523 A dual inhibitor of PI3K and BRD4
- GC19320 SAR-20347 A JAK family kinase inhibitor
- GC19298 PLX51107 A BET family protein inhibitor
-
GC19288
PF-06651600
PF-06651600
PF-06651600 (PF-06651600) 是一种具有口服活性的选择性 JAK3 抑制剂,IC50 为 33.1 nM。 -
GC19264
NMS-P118
2-[1-(4,4-二氟环己基)-4-哌啶基]-6-氟-2,3-二氢-3-氧代-1H-异吲哚-4-甲酰胺
A potent and selective PARP1 inhibitor - GC19251 MK-8617 A HIF-PH1, -2, and -3 inhibitor
-
GC19248
Mivebresib
米维布塞; ABBV-075
A BRD2, BRD4, and BRDT inhibitor - GC19247 MI-503 MI-503 是一种高效且具有口服生物利用度的 menin-mLL 相互作用的小分子抑制剂。
- GC19246 MI-463 An inhibitor of menin-MLL fusion protein interactions
- GC19211 JQEZ5 An EZH2 inhibitor
-
GC19210
JQ-1 carboxylic acid
(6S)-4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F][1,2,4]噻唑并[4,3-A][1,4]二氮杂卓-6-乙酸
A selective inhibitor of BET bromodomains -
GC19204
Itacitinib
伊他替尼,INCB039110
A JAK1 inhibitor - GC19200 INCB-057643 A BET family protein inhibitor
-
GC19190
HDAC-IN-4
CXD101
An HDAC inhibitor -
GC19189
HDAC8-IN-1
MDK-7933
An HDAC8 inhibitor - GC19184 GSK484 hydrochloride GSK484是一种选择性PAD4抑制剂,已被用作抗缺血化合物,对PAD4具有抑制活性。
- GC19181 GSK2807 Trifluoroacetate GSK2807 Trifluoroacetate 是一种有效的、选择性的、SAM 竞争性的 SMYD3 抑制剂,Ki 为 14 nM,IC50 为 130 nM。
-
GC19149
EZM 2302
GSK3359088
A PRMT4 inhibitor - GC19141 EPZ011989 An orally bioavailable EZH2 inhibitor
- GC19130 EED226 A potent and allosteric inhibitor of PRC2
-
GC19129
EDO-S101
Tinostamustine
An HDAC inhibitor and DNA alkylating agent -
GC19119
dBET1
2-((S)-4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F][1,2,4]三唑并[4,3-A][1,4]二氮杂卓-6-基)-N-(4-(2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)氧基)乙酰氨基)丁基)乙酰胺
A hybrid molecule containing (+)-JQ-1 and thalidomide - GC19098 CeMMEC1 A selective TAF1 bromodomain 2 inhibitor
- GC19092 CCT241736 A dual inhibitor of Aurora kinases and FLT3
- GC19038 ARV-825 A BRD4 inhibitor that drives BRD4 degradation
-
GC19020
ACY-738
N-羟基-2-[(1-苯基环丙基)氨基]-5-嘧啶甲酰胺
An HDAC6 inhibitor -
GC19013
3-TYP
吡啶-3-乙炔
3-TYP 抑制 SIRT3,IC50 为 16 nM,比 SIRT1 和 SIRT2 更有效,IC50 分别为 88 nM 和 92 nM。 -
GC18949
CAY10677
Icmt Inhibitor 15
An inhibitor of protein prenylation -
GC18925
Cl-Amidine (hydrochloride)
N-[(1S)-1-(氨基羰基)-4-[(2-氯-1-亚氨基乙基氨基]丁基]-苯甲酰胺盐酸盐
A PAD inhibitor - GC18915 Trapoxin A Trapoxin A is a cyclotetrapeptide histone deacetylase (HDAC) inhibitor.
- GC18731 LP99 A selective inhibitor of BRD7/9
- GC18729 MZ1 A PROTAC that drives BRD4 degradation
-
GC18650
S-(5'-Adenosyl)-L-methionine (tosylate)
S-腺苷蛋氨酸对甲苯磺酸盐,S-Adenosyl methionine tosylate; Ademetionine tosylate; AdoMet tosylate
A methyl donor and cofactor - GC18642 SW155246 A DNA methyltransferase 1 inhibitor
-
GC18623
α-Hydroxyglutaric Acid
2-Hydroxyglutarate; 2-Hydroxyglutaric acid; 2-Hydroxypentanedioic acid
An α-hydroxy acid -
GC18577
CID-2818500
Α-硝基茋
An inhibitor of PRMT1 -
GC18509
3-Methylcytidine (methosulfate)
3-甲基胞苷甲基硫酸酯
An internal standard for HPLC - GC18508 BAY-299 A potent and selective BRD1 inhibitor
- GC18428 SGC2085 (hydrochloride) A PRMT4/CARM1 inhibitor
-
GC18408
BML-278
DIETHYL1-BENZYL-4-PHENYL-1,4-DIHYDROPYRIDINE-3,5-DICARBOXYLATE锛圵S201542锛,WUXIAPPTEC"
An activator of SIRT1, SIRT2, and SIRT3 - GC18402 GSK3117391 An HDAC inhibitor